Literature DB >> 20383190

p53- and p21-dependent premature APC/C-Cdh1 activation in G2 is part of the long-term response to genotoxic stress.

L Wiebusch1, C Hagemeier.   

Abstract

The long-term cellular response to DNA damage is controlled by the tumor suppressor p53. It results in cell-cycle arrest followed by DNA repair and, depending on the degree of damage inflicted, premature senescence or apoptotic cell death. Here we show that in normal diploid fibroblasts the ubiquitin ligase anaphase-promoting complex or cyclosome (APC/C)-Cdh1 becomes prematurely activated in G2 as part of the sustained long-term but not the rapid short-term response to genotoxic stress and results in the degradation of numerous APC/C substrates. Using HCT116 somatic knockout cells we show that mechanistically premature APC/C activation depends on p53 and its transcriptional target p21 that mediates the signal through downregulation of the APC/C inhibitor Emi1. Cdc14B is dispensable in this setting but might function redundantly. Our data suggest an unexpected role for the APC/C in executing a part of the p53-dependent DNA damage response that leads to premature senescence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20383190     DOI: 10.1038/onc.2010.99

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

Review 1.  APC/C-Cdh1: from cell cycle to cellular differentiation and genomic integrity.

Authors:  Xinxian Qiao; Liyong Zhang; Armin M Gamper; Takeo Fujita; Yong Wan
Journal:  Cell Cycle       Date:  2010-10-11       Impact factor: 4.534

Review 2.  Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?

Authors:  Tetyana V Bagnyukova; Ilya G Serebriiskii; Yan Zhou; Elizabeth A Hopper-Borge; Erica A Golemis; Igor Astsaturov
Journal:  Cancer Biol Ther       Date:  2010-11-01       Impact factor: 4.742

Review 3.  Senescence from G2 arrest, revisited.

Authors:  Véronique Gire; Vjekoslav Dulic
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Radiation-induced cellular senescence results from a slippage of long-term G2 arrested cells into G1 phase.

Authors:  Caiyong Ye; Xurui Zhang; Jianghua Wan; Lei Chang; Wentao Hu; Zhitong Bing; Sheng Zhang; Junhong Li; Jinpeng He; Jufang Wang; Guangming Zhou
Journal:  Cell Cycle       Date:  2013-04-09       Impact factor: 4.534

5.  miR-300 regulates cellular radiosensitivity through targeting p53 and apaf1 in human lung cancer cells.

Authors:  Jinpeng He; Xiu Feng; Junrui Hua; Li Wei; Zhiwei Lu; Wenjun Wei; Hui Cai; Bing Wang; Wengui Shi; Nan Ding; He Li; Yanan Zhang; Jufang Wang
Journal:  Cell Cycle       Date:  2017-09-12       Impact factor: 4.534

6.  A rapid screening system evaluates novel inhibitors of DNA methylation and suggests F-box proteins as potential therapeutic targets for high-risk neuroblastoma.

Authors:  Livius Penter; Bert Maier; Ute Frede; Benjamin Hackner; Thomas Carell; Christian Hagemeier; Matthias Truss
Journal:  Target Oncol       Date:  2015-01-06       Impact factor: 4.493

7.  Activation of NF-κB by human papillomavirus 16 E1 limits E1-dependent viral replication through degradation of E1.

Authors:  Tomomi Nakahara; Katsuyuki Tanaka; Shin-ichi Ohno; Nagayasu Egawa; Takashi Yugawa; Tohru Kiyono
Journal:  J Virol       Date:  2015-02-25       Impact factor: 5.103

8.  Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle.

Authors:  Martin Zydek; Christian Hagemeier; Lüder Wiebusch
Journal:  PLoS Pathog       Date:  2010-09-09       Impact factor: 6.823

9.  Tousled-like kinase 2 regulates recovery from a DNA damage-induced G2 arrest.

Authors:  Wytse Bruinsma; Jeroen van den Berg; Melinda Aprelia; René H Medema
Journal:  EMBO Rep       Date:  2016-03-01       Impact factor: 8.807

10.  Oscillation of APC/C activity during cell cycle arrest promotes centrosome amplification.

Authors:  Suzanna L Prosser; Mugdha D Samant; Joanne E Baxter; Ciaran G Morrison; Andrew M Fry
Journal:  J Cell Sci       Date:  2012-09-06       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.